Home › Research › Long-term cohort studies
Plasma neurofilament light chain levels in Alzheimer's disease
Zhou W, Zhang J, Ye F, Xu G, Su H, Su Y, Zhang X, Alzheimer’s Disease Neuroimaging Initiative.. Neuroscience letters, 2017-04-18
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Plasma neurofilament light (NFL) levels may be a marker of neuronal injury. We examined whether plasma NFL might be a potential biomarker for the prodromal and dementia stages of AD. Participants included 193 cognitively normal (CN), 198 amnestic mild cognitive impairment (aMCI) and 187 Alzheimer's disease (AD) individuals enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
What this study adds
Evidence grade: Low
The record lists 193 participants. This study examined whether plasma neurofilament light chain levels differ among cognitively normal, amnestic mild cognitive impairment and Alzheimer's disease participants. It evaluates a potential biomarker, so it does not provide a treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Zhou, W., Zhang, J., Ye, F., Xu, G., Su, H., Su, Y., et al. (2017). Plasma neurofilament light chain levels in Alzheimer's disease. Neuroscience letters. https://doi.org/10.1016/j.neulet.2017.04.027
Vancouver
Zhou W, Zhang J, Ye F, Xu G, Su H, Su Y, et al. Plasma neurofilament light chain levels in Alzheimer's disease. Neuroscience letters. 2017. doi:10.1016/j.neulet.2017.04.027. PMID: 28428015.
BibTeX
@article{zhou2017-28428015,
author = {Zhou, W. and Zhang, J. and Ye, F. and Xu, G. and Su, H. and Su, Y. and Zhang, X. and {Alzheimer’s Disease Neuroimaging Initiative}},
title = {{Plasma neurofilament light chain levels in Alzheimer's disease}},
journal = {Neuroscience letters},
year = {2017},
doi = {10.1016/j.neulet.2017.04.027},
pmid = {28428015},
url = {https://doi.org/10.1016/j.neulet.2017.04.027}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- We examined whether plasma NFL might be a potential biomarker for the prodromal and dementia stages of AD.
- Participants included 193 cognitively normal (CN), 198 amnestic mild cognitive impairment (aMCI) and 187 Alzheimer's disease (AD) individuals enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
- Plasma NFL levels were examined by the Single Molecule array (Simoa) technique.
- Our results showed significantly increased plasma NFL levels in both AD (50.9pg/ml) and aMCI (43.0pg/ml) groups compared to CN (34.7pg/ml) group (both p<0.001), but with substantial overlap between the groups.
Why it matters
This study examined whether plasma neurofilament light chain levels differ among cognitively normal, amnestic mild cognitive impairment and Alzheimer's disease participants. It evaluates a potential biomarker, so it does not provide a treatment, cure or prevention.
Study details
- Participants193
- Evidence strengthLow
How this study scored 49/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neuroscience letters) |
| Journal's citation record | 3 / 4 | Neuroscience Letters: journal h-index 267 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2017 — within 10 year(s) of the newest study here |
| Sample size | 2 / 4 | 193 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 95 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.6 citations a year over 11 year(s) since 2017 |
| Impact for its field and year | 3 / 6 | Cited 8.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 12 other studies in this library |
| Still being cited | 2 / 4 | Cited 17 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Xiangyang Zhang: h-index 10 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Peking University: institution h-index 1,098 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 7 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28428015) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.neulet.2017.04.027
- PubMed: 28428015
- Original source →
- Free full text: Neuroscience Letters →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
12 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Long-term cohort studies from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.